David MacDonald

Directeur Technique/Scientifique/R&D chez XORTX THERAPEUTICS INC.

Health Technology

Consumer Services

Miscellaneous

Postes actifs de David MacDonald

Sociétés	Poste	Début	Fin
XORTX THERAPEUTICS INC.	Directeur Technique/Scientifique/R&D	20/01/2022	-

Historique de carrière de David MacDonald

Anciens postes connus de David MacDonald

Sociétés	Poste	Début	Fin
Immunoflex Therapeutics, Inc.	Directeur Technique/Scientifique/R&D	01/01/2020	01/01/2021
Biovail Contract Research Division	Corporate Officer/Principal	-	-
Hemosol Corp. /Old/ Hemosol Corp. /Old/ Pharmaceuticals: MajorHealth Technology Hemosol Inc. is an integrated biopharmaceutical company focused on the development of a portfolio of products based on human hemoglobin.	Corporate Officer/Principal	-	-
Syntex, Inc.	Corporate Officer/Principal	-	-
MSI Methylation Sciences, Inc. MSI Methylation Sciences, Inc. Pharmaceuticals: MajorHealth Technology MSI Methylation Sciences, Inc. engages in drug development through compound leverage. It focuses on developing pharmaceuticals based on molecules with proven efficacy that are under exploited in pharmaceutical markets. The firm offers s-adenosyl methionine, is a prescription drug used as a dietary supplement. The company was founded by Barry J. Guld and Nancy Harrison in 2006 and is headquartered in Burnaby, Canada.	Directeur Technique/Scientifique/R&D	01/01/2008	01/03/2017
	President	01/03/2017	-
Active Pass Pharmaceuticals, Inc. Active Pass Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Active Pass Pharmaceuticals, Inc. develops drugs for infectious diseases. It engages in the development of drugs that inhibit ABC transporters. The firm also provides portfolio of therapeutic programs, including age-related macular degeneration, travelers' diarrhea, and lipid disorders. The company was founded by Peter B Reiner in 1998 and is headquartered in Vancouver, Canada.	Directeur Général	01/06/2004	-
	President	01/06/2004	-

Formation de David MacDonald

University of Alberta

Doctorate Degree

Statistiques

Internationale

Canada

Opérationnelle

Chief Tech/Sci/R&D Officer	3
Corporate Officer/Principal	3
President	2

Sectorielle

Health Technology	5
Consumer Services	2
Miscellaneous	2

Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Sociétés liées

Sociétés cotées	1
XORTX THERAPEUTICS INC.	Health Technology

Entreprise privées	6
MSI Methylation Sciences, Inc. MSI Methylation Sciences, Inc. Pharmaceuticals: MajorHealth Technology MSI Methylation Sciences, Inc. engages in drug development through compound leverage. It focuses on developing pharmaceuticals based on molecules with proven efficacy that are under exploited in pharmaceutical markets. The firm offers s-adenosyl methionine, is a prescription drug used as a dietary supplement. The company was founded by Barry J. Guld and Nancy Harrison in 2006 and is headquartered in Burnaby, Canada.	Health Technology
Hemosol Corp. /Old/ Hemosol Corp. /Old/ Pharmaceuticals: MajorHealth Technology Hemosol Inc. is an integrated biopharmaceutical company focused on the development of a portfolio of products based on human hemoglobin.	Health Technology
Active Pass Pharmaceuticals, Inc. Active Pass Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Active Pass Pharmaceuticals, Inc. develops drugs for infectious diseases. It engages in the development of drugs that inhibit ABC transporters. The firm also provides portfolio of therapeutic programs, including age-related macular degeneration, travelers' diarrhea, and lipid disorders. The company was founded by Peter B Reiner in 1998 and is headquartered in Vancouver, Canada.	Health Technology
Syntex, Inc.	Miscellaneous
Biovail Contract Research Division	Commercial Services
Immunoflex Therapeutics, Inc.

Voir les connexions sociétés